Compartmentalised signalling and trafficking of CXCR4 and ACKR3
Early stage researcher 11 (ESR11) project
Supervision: Prof. Dr. Meritxell Canals, Dr. Stephen Briddon
Host: University of Nottingham
I – Project proposal:
Aim:
To investigate the compartmentalization of signals generated by CXCR4 and ACKR3.
To assess receptor diffusion within the plasma membrane and endocytosis and to determine its role in the signalling repertoire of CXCR4 and ACKR3.
To use receptor mutatagenesis and knockdown of GRKs, G proteins and arrestins to elucidate the mechanisms of signal compartmentalisation and receptor regulation.
Methodology:
Signal compartmentalization by CXCR4 and ACKR3 will be investigated using genetically encoded biosensors that detect activation of specific signalling cascades (PKC, ERK, cAMP).
Receptor diffusion within the plasma membrane will be assessed using Fluorescence Correlation Spectroscopy (FCS) as well as Total Internal Reflection Fluorescence (TIRF) microscopy. BRET sensors for receptor trafficking and for the recruitment of arrestins will be used to determine the kinetics of receptor endocytosis.
The mechanisms of compartmentalised signalling and receptor trafficking, and the relation between them will be assessed using complementary approaches to inhibit receptor endocytosis in combination with the signalling biosensors and imaging approaches described above.
Planned secondments:
Universitätsklinikum Jena
Universidad Autónoma de Madrid
II – Requirement candidate:
Required diploma: MSc degree in pharmacology, biochemistry or a related discipline
Required expertise: cell culture, cell biology, cell-based assays, molecular biology
Recommended expertise: GPCR molecular pharmacology, imaging, FRET/BRET-based approaches
Key publications:
- Halls, M.L., et al., Plasma membrane localization of the μ-opioid receptor controls spatiotemporal signaling. Science signaling, 2016. 9(414): p. ra16.
- Gondin, A.B., et al., GRK Mediates mu-Opioid Receptor Plasma Membrane Reorganization. Front Mol Neurosci, 2019. 12: p. 104
- Jensen, D.D., et al., Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolong ed pain relief. Science translational medicine, 2017. 9(392).
Briddon, S.J., L.E. Kilpatrick, and S.J. Hill, Studying GPCR Pharmacology in Membrane Microdomains: Fluorescence Correlation Spectroscopy Comes of Age. Trends in pharmacological sciences, 2018. 39(2): p. 158-174.
For more information:
Prof. Dr. Meritxell Canals – meritxell.canals@nottingham.ac.uk
Dr. Stephen Briddon – stephen.briddon@notthingham.ac.uk
Application:
Follow us on
My project will be focused on the role of #CXCR4/ACKR3/GRK2 -governed networks in cancer cell migration and metastasis.
New review on #gpcr structural dynamics out in COSB. Great teamwork with the @JanaSelent group. Thanks to @Lundbeckfonden and @novonordiskfond https://lnkd.in/eyjrA5V
A reminder that applications for our new Deputy Editor in Chief of #PharmacologyMatters close on Monday. https://buff.ly/2PNWf4V
ONCORNET2.0 is the successor to #ONCORNET. You can see some of the work of ESRs from the first ONCORNET in this special issue of @MolPharmJournal from 2019, with reviews on #CXCR4 and #ACKR3 structure and function: https://molpharm.aspetjournals.org/content/96/6
Hi everyone – we’re on Twitter! ONCORNET2.0 is a #MarieCurie ITN of 16 ESRs across Europe studying #chemokine #GPCRs #CXCR4 and #ACKR3 in cancer. Our projects cover molecular dynamics, medchem, #pharmacology through to translational work. Follow us for updates from our ESRs!
Contact details
Please contact us at:
info@oncornet.eu
ONCORNET Coordinator
VU University Amsterdam
The Netherlands